ABVC earnings: real EPS beat/miss history, analyst consensus Hold, P/E -10.27. Updated 2026-07-23.
ABVC BioPharma (ABVC) Research Hub
ABVC BioPharma (ABVC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.9801 USD (+1.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.27, market cap 0.02B. This hub links to the full technical, earnings and options research available for ABVC.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9801 USD (+1.04%) |
| 52-week range | 0.7069 USD – 2.15 USD |
| Trend regime | Range |
| 14-day RSI | 48 (Neutral) |
| Trailing P/E | -10.27 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for ABVC
Covered Call on ABVC: how it works, illustrative setup around the real 0.9801 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABVC: how it works, illustrative setup around the real 0.9801 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABVC: how it works, illustrative setup around the real 0.9801 USD price, max profit/loss, breakeven and when to use it. Educational.
ABVC technical analysis: range, last 0.9801 USD, RSI 48, 52w range 0.7069 USD–2.15 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ABVC in?
ABVC BioPharma (ABVC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABVC in an uptrend or downtrend?
As of 2026-09-11, ABVC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABVC's trailing P/E ratio?
ABVC's trailing P/E is -10.27, with a market cap of 0.02B. See the earnings research page for full valuation detail.